Filing Details

Accession Number:
0001104659-22-067758
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-02 20:00:41
Reporting Period:
2022-06-01
Accepted Time:
2022-06-02 20:00:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1425205 Iovance Biotherapeutics Inc. IOVA Biological Products, (No Disgnostic Substances) (2836) 753254381
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1719678 G Frederick Vogt C/O Iovance Biotherapeutics, Inc.
825 Industrial Road, 4Th Floor
San Carlos CA 94070
Interim Ceo & General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-06-01 1,000 $6.44 1,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct